George A. Călin

783 total papers · 44.2k total citations
315 papers, 29.8k citations indexed

About

George A. Călin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, George A. Călin has authored 315 papers receiving a total of 29.8k indexed citations (citations by other indexed papers that have themselves been cited), including 255 papers in Molecular Biology, 247 papers in Cancer Research and 36 papers in Oncology. Recurrent topics in George A. Călin's work include MicroRNA in disease regulation (189 papers), Cancer-related molecular mechanisms research (162 papers) and Circular RNAs in diseases (102 papers). George A. Călin is often cited by papers focused on MicroRNA in disease regulation (189 papers), Cancer-related molecular mechanisms research (162 papers) and Circular RNAs in diseases (102 papers). George A. Călin collaborates with scholars based in United States, Romania and Italy. George A. Călin's co-authors include Muller Fabbri, Hui Ling, Gabriel Lopez‐Berestein, Anil K. Sood, Klaus Pantel, Cristina Ivan, Maria Inês Almeida, María Angélica Cortez, Ioana Berindan‐Neagoe and Mihnea P. Dragomir and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

George A. Călin

309 papers receiving 29.5k citations

Hit Papers

Non-coding RNAs and cance... 2011 2026 2016 2021 2011 2014 2013 2011 2021 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Non-coding RNAs and cancer: microRNAs and beyond
    2011 3.0k citations George A. Călin et al. profile →
  2. Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis
    2014 1.2k citations Sónia A. Melo, Hikaru Sugimoto et al. Cancer Cell profile →
  3. MicroRNAs and other non-coding RNAs as targets for anticancer drug development
    2013 1.2k citations Hui Ling, Muller Fabbri et al. Nature Reviews Drug Discovery profile →
  4. MicroRNAs in body fluids—the mix of hormones and biomarkers
    2011 1.2k citations María Angélica Cortez, Carlos E. Bueso‐Ramos et al. Nature Reviews Clinical Oncology profile →
  5. Noncoding RNA therapeutics — challenges and potential solutions
    2021 1.1k citations Melanie Winkle, Sherien M. El‐Daly et al. Nature Reviews Drug Discovery profile →
  6. Clinical relevance of circulating cell-free microRNAs in cancer
    2014 858 citations Heidi Schwarzenbach, Naohiro Nishida et al. Nature Reviews Clinical Oncology profile →
  7. Long non-coding RNAs and cancer: a new frontier of translational research?
    2012 836 citations Riccardo Spizzo, Maria Inês Almeida et al. Oncogene profile →
  8. PDL1 Regulation by p53 via miR-34
    2015 531 citations María Angélica Cortez, Cristina Ivan et al. JNCI Journal of the National Cancer Institute profile →
  9. miRNA Deregulation in Cancer Cells and the Tumor Microenvironment
    2016 530 citations Rajesha Rupaimoole, George A. Călin et al. Cancer Discovery profile →
  10. Long Noncoding RNA in Prostate, Bladder, and Kidney Cancer
    2013 523 citations Elena S. Martens‐Uzunova, René Böttcher et al. European Urology profile →
  11. The multiMiR R package and database: integration of microRNA–target interactions along with their disease and drug associations
    2014 468 citations Yuanbin Ru, Katerina Kechris et al. Nucleic Acids Research profile →
  12. PD-L1 expression and prognostic impact in glioblastoma
    2015 456 citations Edjah K. Nduom, Jun Wei et al. Neuro-Oncology profile →
  13. Non-coding RNAs in disease: from mechanisms to therapeutics
    2023 391 citations Kinga Németh, Recep Bayraktar et al. Nature Reviews Genetics profile →
  14. MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance
    2018 356 citations Mohammad Askandar Iqbal, Shweta Arora et al. Molecular Aspects of Medicine profile →
  15. RNAi-based therapeutics and tumor targeted delivery in cancer
    2022 282 citations Göknur Kara, George A. Călin et al. Advanced Drug Delivery Reviews profile →
  16. Targeting non-coding RNAs to overcome cancer therapy resistance
    2022 261 citations Baoqing Chen, Mihnea P. Dragomir et al. Signal Transduction and Targeted Therapy profile →
  17. Going circular: history, present, and future of circRNAs in cancer
    2023 134 citations Giuseppina Pisignano, Tanvi H. Visal et al. Oncogene profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
George A. Călin 23.4k 21.1k 3.1k 2.7k 1.8k 315 29.8k
Stefano Volinia 31.9k 1.4× 24.8k 1.2× 3.8k 1.2× 3.2k 1.2× 1.3k 0.7× 240 39.3k
Guiyuan Li 15.7k 0.7× 11.5k 0.5× 5.4k 1.7× 3.8k 1.4× 2.1k 1.2× 461 23.4k
Massimo Negrini 31.9k 1.4× 27.7k 1.3× 4.1k 1.3× 2.8k 1.0× 1.6k 0.9× 262 40.0k
Manuela Ferracin 19.8k 0.8× 18.7k 0.9× 1.9k 0.6× 1.8k 0.7× 997 0.5× 161 24.8k
Takahiro Ochiya 24.0k 1.0× 16.6k 0.8× 3.2k 1.0× 2.4k 0.9× 2.4k 1.3× 465 31.0k
Li Ma 13.5k 0.6× 7.6k 0.4× 3.0k 0.9× 1.6k 0.6× 2.0k 1.1× 259 18.2k
Erwei Song 14.3k 0.6× 10.0k 0.5× 6.3k 2.0× 4.4k 1.6× 1.8k 1.0× 227 22.5k
Dylan R. Edwards 9.5k 0.4× 9.1k 0.4× 6.2k 2.0× 2.8k 1.0× 1.6k 0.9× 233 22.9k
Gideon Rechavi 18.5k 0.8× 6.0k 0.3× 3.7k 1.2× 2.8k 1.0× 1.3k 0.7× 405 26.9k
Christopher M. Overall 11.8k 0.5× 10.8k 0.5× 9.5k 3.0× 2.7k 1.0× 1.0k 0.6× 296 28.1k

Countries citing papers authored by George A. Călin

Since Specialization
Citations

This map shows the geographic impact of George A. Călin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George A. Călin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George A. Călin more than expected).

Fields of papers citing papers by George A. Călin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George A. Călin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George A. Călin. The network helps show where George A. Călin may publish in the future.

Co-authorship network of co-authors of George A. Călin

This figure shows the co-authorship network connecting the top 25 collaborators of George A. Călin. A scholar is included among the top collaborators of George A. Călin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George A. Călin. George A. Călin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donald M. Anderson Breakdown of academic impact, for papers by Guojun Bu Breakdown of academic impact, for papers by Pak H. Chan Breakdown of academic impact, for papers by Ueli Aebi Breakdown of academic impact, for papers by Russell K. Portenoy Breakdown of academic impact, for papers by James W. Vaupel Breakdown of academic impact, for papers by Jeffrey B. Neaton Breakdown of academic impact, for papers by Joan Rodés
Rankless by CCL
2026